The activator hypermethylation sequences of GSTP1, MGMT, p16, and DAPK have been employed as molecular identifiers for identifying tumor cells in DNA serum, and over half of the individuals with HNSCC and methylated tumours had similar epigenetic abnormalities in the matched serum [41]. This evidence concerns the gene MGMT and neoplasm.